Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC0242 Gsk1360707 Novel potent and selective triple reuptake inhibitor (TRI)
DCC0243 4991w93 5HT(1B/1D) receptor partial agonist, inhibiting electrically induced plasma extravasation, blocking neurogenic plasma protein extravasation, inhibiting release of calcitonin gene-related peptide
DCC0244 4'-acetoxy-resveratrol Antioxidant, significantly increased gene expression of the anti-aging factor, SIRT1, stimulating the expression of skin growth factor and inhibiting pro-inflammatory genes
DCC0245 4-acetylantroquinonol B Natural inhibitor of the autophagy pathway, enhancing immune function, suppressing MAPK and NFκB, showing anti-inflammatory, hypoglycemic, vasorelaxative, and antiproliferative activities
DCC0246 4-acpam Selectiveγ
DCC0247 4-acpca Selectiveγ
DCC0248 4-acpha Selectiveγ‑Aminobutyric Acid(C) (GABAC) Antagonist
DCC0249 4alpha,5alpha-oxidoeudesm-11-en-3-one Natural selective estrogen receptor modulator, showing higher binding affinity to ER-β than ER-α with both estrogenic and antiestrogenic effects depending on the E2 concentration
DCC0250 4-azido-l-phenylalanine Hydrochloride Mutually Orthogonal Bioorthogonal Amino Acid, Enabling Efficient Protein Dual-Labeling in Cells
DCC0251 4-azido-n-ethyl-1,8-naphthalimide Clickable fluorescent probe, enabling dynamic imaging of cell surface and intracellular fucosylation of glycoproteins and glycolipids.
DCC0252 4-benzoyl-l-phenylalanine Photoreactive L-phenylalanine derivative, being as a photo cross-linking probe to incorporate into proteins, including ion channels, transporters and GPCRs
DCC0253 4-bromo-a23187 Ca ionophore. potentiating responses to NMDA, but not quisqualate
DCC0254 4'-carboxybenzo-18c6 Novel Transthyretin (TTR) Amyloidogenesis Inhibitor, stabilizing the TTR tetramer by binding to the allosteric sites on the molecular surface of the TTR tetramer
DCC0255 4-chlorokynurenine Prodrug of 7-Cl-kynurenic acid (7-Cl-KYNA), a potent, selective antagonist of the NMDA/glycine receptor
DCC0256 4-cl-imt Novel selective ligand of the Transport Inhibitor Resistant 1 (TIR1)
DCC0257 4-cyclopentene-1,3-dione Potent Antifungal Inhibitor of Chitin Synthesis
DCC0258 4'-dma-7,8-dhf Potent agonist of tropomyosin-receptor-kinase B (TrkB) receptor, possessing robust anti-apoptotic activity, promoting neurogenesis, and exhibiting potent antidepressant effect
DCC0259 4-fluoroamphetamine Hydrochloride Dopamine reuptake inhibitor
DCC0260 4-me-pdtic Novel Potent and Selective Kappa Opioid Receptor Antagonist
DCC0261 4-ome-arm1 Novel ligand for LTA4H, dose responsively reducing LTB4 production in human neutrophils
DCC0262 4'-o-methylgrynullarin Novel anti-austerity agent, inducing PANC-1 human pancreatic cancer cell death under nutrition starvation via inhibition of Akt/mTOR pathway
DCC0263 4'-o-methylresveratrol Inhibitor of Androgen_receptor>androgen receptor (AR) transcriptional activity, more effective than resveratrol in inhibiting AKT>Akt phosphorylation
DCC0264 4-pridin-4-yl-2h-pyrazol-3-ylamine Useful pharmaceutical building block
DCC0265 4-quinolin-4-yl-2h-pyrazol-3-ylamine Useful pharmaceutical building block
DCC0266 4-quinolineacetonitrile Bulding Block
DCC0267 5,6-eet Inhibitor of T-type voltage-gated calcium channels (Cav3), inhibiting isoforms Cav3.1, Cav3.2, and Cav3.3, decreasing nifedipine-resistant phenylephrine-induced vasoconstriction via Cav3.2 blockade
DCC0268 5172-mcp1p3 Novel inhibitor of HCV NS3-NS4A Serine Proteinase
DCC0269 5-actmf Novel Inducer of G2/M arrest, Apoptosis and Autophagy in Cancer Cells
DCC0270 5-alpha-hydroxy-laxogenin Featured 5-alpha-hydroxy-laxogenin is a derivative of the spirostane-type steroid, laxogenin. 5α-Hydroxy-laxogenin can be used as a plant-based anabolic agent as a dietary supplement.
DCC0271 5'-amino-5'-deoxyadenosine Adenosine kinase inhibitor

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X